SLOT: Full Definition
What is thyroid eye disease?
Thyroid eye disease — also called Graves' ophthalmopathy, Graves' eye disease, or TED — is an autoimmune condition in which the immune system attacks the tissues behind and around the eye, causing inflammation, swelling, and progressive changes in eye position and function. It is most often associated with Graves Disease, occurring in roughly 25-50% of Graves' patients, though it can also occur (less commonly) in Hashimotos Thyroiditis or in people with normal thyroid function. Symptoms range from mild dry eye and irritation to severe pain, double vision, bulging of the eyes (exophthalmos), and, in rare cases, vision loss. TED is more common in women than men, but tends to be more severe in men and in smokers.
What causes thyroid eye disease?
TED shares the autoimmune basis of Graves' disease. The TSH receptor — the same receptor stimulated by Graves' antibodies in the thyroid — is also present on cells behind the eye (orbital fibroblasts and fat cells). When antibodies activate these receptors, the orbital tissues swell, accumulate fluid and fat, and become inflamed. Risk factors include smoking (the strongest modifiable risk factor — TED is significantly worse in smokers), uncontrolled hyperthyroidism, radioactive iodine treatment without protective steroids in high-risk patients, female sex, family history, and genetic susceptibility. The active inflammatory phase typically lasts six months to two years, followed by a stable phase in which symptoms may improve but residual changes often remain.
How is thyroid eye disease diagnosed?
Diagnosis is clinical, supported by labs and imaging. The combination of eye symptoms (irritation, redness, pressure, double vision, bulging) with hyperthyroidism or known Graves' disease is highly suggestive. Lab work includes TSH, Free T4, Free T3, and Graves' antibodies (TSI, TRAb), which are typically elevated in TED even when thyroid function has been treated. Imaging — usually orbital MRI or CT — shows enlarged extraocular muscles, increased orbital fat, and inflammation. An ophthalmologist with specific expertise in TED is essential for grading severity (mild, moderate-to-severe, sight-threatening) and guiding treatment. Modern Thyroid Clinic does not treat TED directly; we coordinate with ophthalmology while managing the underlying thyroid disease.
How is thyroid eye disease treated?
Treatment depends on severity and phase. Mild cases focus on supportive care: artificial tears, lubricating ointments, sleeping with the head elevated, sunglasses, and selenium supplementation, which has shown benefit in mild active disease. Smoking cessation is critical and improves outcomes substantially. Moderate-to-severe active disease may be treated with intravenous corticosteroids, biologic medications (such as teprotumumab, the first FDA-approved treatment specifically for TED), or orbital radiotherapy. Surgical treatments — orbital decompression, eye muscle surgery, eyelid surgery — are typically reserved for the stable phase to address residual changes. Throughout, controlling the underlying Hyperthyroidism is essential, as both hyperthyroidism and untreated hypothyroidism can worsen TED.
Common symptoms
Common questions
Will my eyes go back to normal after thyroid eye disease?
Often substantially, but not always completely. The active inflammatory phase typically settles within six months to two years, after which symptoms stabilize. Many women see significant improvement in pain, redness, and swelling, but some changes — particularly mild bulging or eyelid retraction — may persist and require surgical correction once the disease is stable. Early treatment, smoking cessation, and tight control of thyroid function all improve the long-term outcome. Newer biologic treatments have meaningfully improved results for patients with moderate to severe active disease.
Why does smoking matter so much in thyroid eye disease?
Smoking is the single most important modifiable risk factor for TED. Smokers are several times more likely to develop TED, develop more severe disease, respond less well to treatment, and have higher rates of progression after radioactive iodine. The mechanism appears to involve direct inflammatory effects on orbital tissues and increased oxidative stress. Quitting smoking — even after diagnosis — meaningfully improves the trajectory. This is one of the strongest interventions available for anyone with Graves' disease, regardless of whether eye symptoms have started.
Can I have thyroid eye disease without Graves' disease?
Yes, though it's much less common. About 5-10% of TED patients are euthyroid (normal thyroid function) at the time of diagnosis, and a small percentage have Hashimoto's rather than Graves'. Many of these patients still have detectable Graves'-type antibodies (TSI, TRAb) and may develop overt hyperthyroidism later. Anyone with classic TED symptoms — bulging eyes, double vision, eyelid retraction — should have a complete thyroid workup including antibody testing, even if standard thyroid labs initially look normal.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.